5,6-Ring Annulated Indole Derivatives for HCV Replication Inhibition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for Hepatitis C virus (HCV) infection are plagued by poor efficacy and unfavorable side effects, with a need for non-peptide, small-molecule compounds that can effectively inhibit HCV replication and treat related disorders.
Innovation Solution
Development of 5,6-ring annulated indole derivatives, including their pharmaceutically acceptable salts, solvates, esters, and prodrugs, which can be administered to patients to treat or prevent viral infections and virus-related disorders by inhibiting HCV replication.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for HCV infection are used, then viral infection can be treated, but efficacy is poor and side effects are unfavorable
Solution Approach 1:
The patent employs parameter changes by developing novel 5,6-ring annulated indole derivatives with modified chemical structures compared to existing HCV treatments. The specific structural parameters (ring annulation, substituent positions) are optimized to enhance antiviral efficacy while reducing cytotoxicity and other adverse effects associated with conventional therapies
Solution Approach 2:
The invention creates composite molecular structures by combining the indole core with various 5,6-ring annulated systems and diverse substituent groups. This composite approach allows optimization of pharmacological properties, achieving better efficacy-toxicity ratio by integrating multiple functional moieties into a single molecular entity
2Reliability
If non-peptide, small-molecule compounds are developed, then HCV replication can be inhibited, but compound complexity increases
Solution Approach 1:
The patent applies segmentation by dividing the complex molecular structure into distinct functional segments: the core indole system, the 5,6-ring annulated portion, and various substituent groups (R1-R6). This modular segmentation allows systematic optimization of each segment's contribution to HCV inhibition while managing overall molecular complexity
Solution Approach 2:
The invention implements local quality by assigning specific functional roles to different regions of the molecule. The 5,6-ring annulated indole core provides the essential binding interaction with HCV targets, while specific substituents at defined positions enhance selectivity and potency. This localized functional assignment optimizes antiviral activity without requiring excessive molecular complexity throughout the entire structure
Data Source
AI summary
The present invention relates to 5,6-ring annulated indole derivatives of the formula (I), compositions comprising at least one 5,6-ring annulated indole derivatives, and methods of using the 5,6-ring annulated indole derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.